Evidence map›Paper›PMID 26912519›Full record

ArticleBrain : a journal of neurology2016

In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.

Susan E Tomlinson, S Veronica Tan, David Burke, Robyn W Labrum, Andrea Haworth, Vaneesha S Gibbons, Mary G Sweeney, Robert C Griggs, Dimitri M Kullmann, Hugh Bostock and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Susan E Tomlinson1 Sydney Medical School, University of Sydney, Australia 2 Department of Neurology, St Vincent's Hospital, Sydney, Australia susan.tomlinson@sydney.edu.au.
S Veronica Tan3 Institute of Neurology, University College London and MRC Centre for Neuromuscular Disease, Queen Square, UK.
David Burke1 Sydney Medical School, University of Sydney, Australia 4 Department of Neurology, Royal Prince Alfred Hospital, Sydney, Australia.
Robyn W Labrum5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
Andrea Haworth5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
Vaneesha S Gibbons5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
Mary G Sweeney5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
Robert C Griggs6 University of Rochester, New York, USA.
Dimitri M Kullmann3 Institute of Neurology, University College London and MRC Centre for Neuromuscular Disease, Queen Square, UK 5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
Hugh Bostock3 Institute of Neurology, University College London and MRC Centre for Neuromuscular Disease, Queen Square, UK.
Michael G Hanna3 Institute of Neurology, University College London and MRC Centre for Neuromuscular Disease, Queen Square, UK 5 Neurogenetics Unit, National Hospital for Neurology, Queen Square, UK.
National Hospital for Neurology and Neurosurgery · GBQueen Mary University of London · GBRoyal Prince Alfred Hospital · AUSydney Hospital · AUUniversity of Rochester · US

Funding

Nervous System Channelopathies: Pathogenesis & TreatmentU54NS059065 · NINDS · UNIVERSITY OF ROCHESTER · PI GRIGGS, ROBERT C · 2006 to 2010
$5.9M
Medical Research Council G0200373Medical Research Council G0801316Medical Research Council G0802158Medical Research Council G116/147Medical Research Council MR/K000608/1Medical Research Council MR/L01095X/1NINDS NIH HHS 5 U54 NS 059065Wellcome Trust
6 · The paper itself

Abstract

Ion channel dysfunction causes a range of neurological disorders by altering transmembrane ion fluxes, neuronal or muscle excitability, and neurotransmitter release. Genetic neuronal channelopathies affecting peripheral axons provide a unique opportunity to examine the impact of dysfunction of a single channel subtype in detail in vivo. Episodic ataxia type 2 is caused by mutations in CACNA1A, which encodes the pore-forming subunit of the neuronal voltage-gated calcium channel Cav2.1. In peripheral motor axons, this channel is highly expressed at the presynaptic neuromuscular junction where it contributes to action potential-evoked neurotransmitter release, but it is not expressed mid-axon or thought to contribute to action potential generation. Eight patients from five families with genetically confirmed episodic ataxia type 2 underwent neurophysiological assessment to determine whether axonal excitability was normal and, if not, whether changes could be explained by Cav2.1 dysfunction. New mutations in the CACNA1A gene were identified in two families. Nerve conduction studies were normal, but increased jitter in single-fibre EMG studies indicated unstable neuromuscular transmission in two patients. Excitability properties of median motor axons were compared with those in 30 age-matched healthy control subjects. All patients had similar excitability abnormalities, including a high electrical threshold and increased responses to hyperpolarizing (P < 0.00007) and depolarizing currents (P < 0.001) in threshold electrotonus. In the recovery cycle, refractoriness (P < 0.0002) and superexcitability (P < 0.006) were increased. Cav2.1 dysfunction in episodic ataxia type 2 thus has unexpected effects on axon excitability, which may reflect an indirect effect of abnormal calcium current fluxes during development.

Indexed as

AdultAgedAtaxiaAxonsCalcium ChannelsCalcium Channels, N-TypeElectromyographyFemaleHumansMaleMiddle AgedMotor NeuronsNystagmus, PathologicPresynaptic TerminalsYoung AdultCACNA1A protein, humanCalcium ChannelsCalcium Channels, N-Typeaxonal excitabilitychannelopathy

Identifiers

PMID26912519
PMCPMC4795516
OpenAlexW2256788691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.